secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pulmonx Corp (LUNG)
CIK:        0001127537
Form:       8-K
Filed at:   2024-04-02T23:59:59+00:00
Accession:  0001127537-24-000039
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulmonx appoints Mehul Joshi as CFO effective April 3, 2024
-----------------------------------------------------------

- Mehul Joshi named CFO; previously CFO of PhenomeX and senior finance roles at ResMed and Gilead.
- Annual base salary $450K; target bonus 50% of base; sign-on bonus $200K with clawback provisions.
- Initial equity grants: non-statutory stock option valued at $1.375M and RSU valued at $1.35M, both vesting over 4 years.
- John McKune, interim CFO since Oct 2023, returns to VP Finance and Corporate Controller.
- Severance and change-in-control benefits: 12 months salary plus bonus acceleration upon qualifying termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1127537/000112753724000039/0001127537-24-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1127537/000112753724000039/lung-20240402.htm
  HTML page:      https://secwatch.observer/filing/0001127537-24-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer